...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Activation of blood coagulation in patients undergoing postoperative blood salvage and re-infusion of unwashed whole blood after total knee arthroplasty.
【24h】

Activation of blood coagulation in patients undergoing postoperative blood salvage and re-infusion of unwashed whole blood after total knee arthroplasty.

机译:全膝关节置换术后接受血液挽救和未冲洗的全血再输注的患者的凝血功能激活。

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Perioperative blood salvage is commonly used in cardiovascular surgery and has been more recently introduced in major orthopedic surgery. Limited information is available on the influence of re-infused whole blood on the hemostatic system in orthopedic patients. Materials and methods: The aim of this study was to assess whether perioperative salvage and re-infusion of unwashed whole blood is associated with an activation of blood coagulation in patients undergoing total knee replacement. Consecutive patients receiving re-infusion were included in the study (n=13). Patients undergoing total knee replacement without perioperative blood salvage and re-infusion served as controls (n=6). In patients receiving re-infusion thrombin-antithrombin complexes (TAT), plasmin-antiplasmin complexes (PAP) and fibrinogen were assayed at the following times: before surgery (baseline), immediately before re-infusion (T0), immediately (T1), 2 h (T2) and 24 h (T3) after the end of re-infusion. In control patients blood samples were drawn at the average times corresponding to each of the sampling time in the patients receiving re-infusion. The first post-surgery LMWH dose was given within 12 h after surgery. Results: TAT and PAP increased after surgery both in patients receiving re-infusion and controls. An increase of TAT and PAP was observed immediately after re-infusion with respect to baseline (TAT 513.1+/-259.1 microg/l vs. 5.3+/-4.9, p<0.0001; PAP 7408.0+/-1892.1 microg/l vs. 461.4+/-217.1, p<0.0001) and to controls (TAT 60.4+/-26.9 microg/l, p=0.002; PAP 2208.3+/-1446.4 microg/l, p<0.001). The levels of TAT and PAP in patients receiving re-infusion remained high at 2 h after re-infusion compared to those of the controls (TAT 124.1+/-38.3 microg/l vs. 38.08+/-18.9, p=0.016; PAP 5690.7+/-1435.5 microg/l vs. 1613.9+/-706.0, p<0.001) and decreased 24 h thereafter. Fibrinogen level was lower in patients receiving re-infusion compared to controls. Conclusions: Whole blood re-infusion is associated with an activation of blood coagulation in patients undergoing total knee replacement. The clinical relevance of this activation has to be tested in prospective studies with adequate sample size.
机译:背景:围手术期的血液抢救通常用于心血管外科手术,最近已在大型骨科手术中引入。关于骨科患者回输全血对止血系统影响的信息有限。材料和方法:这项研究的目的是评估在进行全膝置换的患者中,围手术期的抢救和未冲洗全血的重新输注是否与凝血激活有关。连续接受输注的患者包括在研究中(n = 13)。接受全膝关节置换术但未进行围手术期抢救和再次输注的患者作为对照(n = 6)。在接受再次输注凝血酶-抗凝血酶复合物(TAT)的患者中,在以下时间检测纤溶酶-抗纤溶酶复合物(PAP)和纤维蛋白原:手术前(基线),紧接重输之前(T0),立即(T1),重新输注结束后2小时(T2)和24小时(T3)。在对照患者中,在对应于接受再输注的患者中每个采样时间的平均时间抽取血液样品。术后12小时内给予首次手术后LMWH剂量。结果:接受再输注的患者和对照组的患者术后TAT和PAP均升高。重新输注后立即观察到TAT和PAP相对于基线增加(TAT 513.1 +/- 259.1 microg / l vs. 5.3 +/- 4.9,p <0.0001; PAP 7408.0 +/- 1892.1 microg / l vs. 461.4 +/- 217.1,p <0.0001)和对照(TAT 60.4 +/-26.9μg/ l,p = 0.002; PAP 2208.3 +/-1446.4μg/ l,p <0.001)。与对照组相比,接受再输注的患者在再输注2 h时TAT和PAP的水平仍然很高(TAT 124.1 +/- 38.3 microg / l与38.08 +/- 18.9,p = 0.016; PAP分别为5690.7 +/- 1435.5 microg / l和1613.9 +/- 706.0微克/升,p <0.001),此后24小时下降。与对照相比,接受再次输注的患者的纤维蛋白原水平较低。结论:全膝置换患者全血回输与凝血功能活化有关。必须在前瞻性研究中以足够的样本量测试这种激活的临床相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号